- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02683993
Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings
August 28, 2017 updated by: Lumenis Be Ltd.
Twenty (20) subjects presenting with a renal stone and candidates for FURS (flexible ureteroscopic renal surgery) will undergo a single FURS procedure for a kidney stone as part of the study, using the study device.
These subjects will be randomized into stone breaking treatment or stone dusting.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 11215
- New York Methodist Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject will be older than 18 years of age
Subject was diagnosed with renal calculi meeting the following criteria:
- Largest stone measures no more than 2cm on a single diameter and is no less than 0.8cm as defined by X-ray or CT.
- Accumulative stone burden (addition of all stone diameters) is no more than 2.5cm.
- Subject is a candidate for FURS procedure
- Subject is willing and has signed the Informed Consent Form
Exclusion Criteria:
- Subject has undergone a previous treatment for stones in the same kidney
- Subject requires another, concomitant procedure, other than FURS, to be performed during this treatment session.
- Female subject is pregnant
- Concomitant anticoagulant medication that cannot be suspended during surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Stone breaking
Lithotripsy will be performed using the Lumenis Pulse 120H holmium laser system with low frequency parameters.
|
The Lumenis Pulse P120H will be utilized in high and low frequencies according to subjects group allocation.
|
Experimental: Stone dusting
Lithotripsy will be performed using the Lumenis Pulse 120H holmium laser system with high frequency parameters.
|
The Lumenis Pulse P120H will be utilized in high and low frequencies according to subjects group allocation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stone Clearance
Time Frame: Stone clearance based on 1 month follow-up imaging data as compared to baseline
|
stone clearance will be confirmed by CT or X-Ray at 1 month follow up.
|
Stone clearance based on 1 month follow-up imaging data as compared to baseline
|
Duration of catheterization time
Time Frame: Change from 1 month to baseline
|
Duration of catheterization will be measured to evaluate treatment efficiency
|
Change from 1 month to baseline
|
Procedure time
Time Frame: during the procedure
|
duration of the procedure as an indicator for treatment efficiency.
|
during the procedure
|
Usage of alternative stone extracting devices
Time Frame: as measured during the procedure
|
The need of the surgeon to use baskets, forceps or saline flushing to achieve complete stone clearance.
This outcome can influence both procedure time and further complication.
|
as measured during the procedure
|
hospital stay
Time Frame: Change from 1 month to baseline
|
hospital duration will be measured to evaluate treatment efficiency
|
Change from 1 month to baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intraoperative Complications
Time Frame: during the procedure and during 1 month follow up
|
Intraoperative Complications will be evaluated based on Modified Clavien Classification- Modified Clavien Grading: Grade 1,Grade 2,Grade 3,Grade 3a,Grade 3b,Grade 4,Grade 4a, Grade 4b, Grade 5. |
during the procedure and during 1 month follow up
|
Visibility during procedure
Time Frame: during the procedure
|
clear vision of the stone and organ compartments as reflected via endoscope and video screen.
|
during the procedure
|
Occurrence of retropulsion that interferes with procedure
Time Frame: during the procedure
|
The subjective degree of stone movement and migration as a result of the laser treatment that interfere with procedure flow.
|
during the procedure
|
Fiber performance
Time Frame: during the procedure
|
The surgeon will evaluate the degree of Fiber flexibility with scope deflection- and any damage to fiber, Fiber durability- deflection without losing energy/ efficiency and any Damage to scope.
|
during the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2016
Primary Completion (Anticipated)
September 1, 2017
Study Completion (Anticipated)
September 1, 2017
Study Registration Dates
First Submitted
January 28, 2016
First Submitted That Met QC Criteria
February 11, 2016
First Posted (Estimate)
February 17, 2016
Study Record Updates
Last Update Posted (Actual)
August 29, 2017
Last Update Submitted That Met QC Criteria
August 28, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LUM-SBU-VP-15-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stone Clearance
-
Hepatopancreatobiliary Surgery Institute of Gansu...Completed
-
Universitaire Ziekenhuizen KU LeuvenCompletedPrevalence of Augmented Renal Clearance | Risk Factors for Augmented Renal ClearanceBelgium
-
Shanghai 10th People's HospitalNot yet recruitingAirway Clearance ImpairmentChina
-
Eastern Virginia Medical SchoolUnknown
-
AstraZenecaRecruitingMucociliary ClearanceUnited States
-
Rush University Medical CenterRecruiting
-
Duke UniversityTeleflexTerminated
-
The Cleveland ClinicEisai Inc.Withdrawn
-
National Taiwan University HospitalCompletedEstimated Creatinine Clearance
-
Hospital de Clinicas de Porto AlegreCompletedPhysical Disability | Mucociliary Clearance Defect